← Back to Directory

Omega Healthcare Investors, Inc. (OHI) - Latest Market Data

Track the most recent price, market cap, volume, and performance data for Omega Healthcare Investors, Inc. (OHI).

Download StockRank on Google Play Download StockRank on the App Store

Equity Details

Price & Market Data

Price: $47.65

Daily Change: +$0.64 / 1.34%

Daily Range: $46.82 - $47.74

Market Cap: $14,857,098,240

Daily Volume: 1,858,316

Performance Metrics

1 Week: 3.32%

1 Month: 4.91%

3 Months: 4.86%

6 Months: 9.44%

1 Year: 32.77%

YTD: 7.47%

About Omega Healthcare Investors, Inc. (OHI)

A snapshot of Omega Healthcare Investors, Inc. (OHI)'s current market standing: priced at 47.65, with a daily adjustment of +$0.64 / 1.34%. Market cap at 14,857,098,240. Performance over the last 6 months (9.44%) and YTD are particularly insightful.

Company Details

Employees: 69

Sector: Finance

Industry: Real estate investment trusts

Country: United States

Details

Omega Healthcare Investors, Inc. is a Real Estate Investment Trust. The firm is providing financing and capital to the long-term healthcare industry in the United States and the United Kingdom with a focus on skilled nursing and assisted living facilities, including care homes in the United Kingdom. As of September 30, 2025, Omega has a portfolio of investments that includes 1,024 operating facilities located in 42 states, the District of Columbia and the United Kingdom/Jersey (290 facilities) and operated by 88 different operators. Additionally, Omega has investments in several unconsolidated entities that own 19 facilities. As a source of capital to the healthcare industry, Omega continually evaluates the opportunities, trends and challenges affecting the industry. Our goal is to identify long-term investments in quality healthcare properties with outstanding operators that provide the most favorable risk/reward ratio to our investors.

Selected stocks

Innovative Industrial Properties, Inc. (IIPR)

Tenon Medical, Inc. (TNON)

Lichen International Limited (LICN)

Xilio Therapeutics, Inc. (XLO)

Morgan Stanley (MS)